BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$301.92 USD
+5.10 (1.72%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $302.11 +0.19 (0.06%) 4:42 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: AMC |
6/2024 | $2.12 | 0.00% |
Earnings Summary
For their last quarter, BioRad Laboratories (BIO) reported earnings of $2.29 per share, beating the Zacks Consensus Estimate of $2.04 per share. This reflects a positive earnings surprise of 12.25%. Look out for BIO's next earnings release on August 01, 2024. For the next earning release, we expect the company to report earnings of $2.12 per share, reflecting a year-over-year decrease of 29.33%.
Earnings History
Price & Consensus
Zacks News for BIO
Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now?
BIO: What are Zacks experts saying now?
Zacks Private Portfolio Services